ODYSSEY (Klaar)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients who have Recently Experienced an Acute Coronary Syndrome.
- Middel
- alirocumab
- Populatie
- ASCVD
- Fase
- IIIb
- Jaar aanvang
- 2012
- Meer informatie
- ClinicalTrials.gov